HighTower Advisors, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$4,721,000
-12.9%
335,516
-40.2%
0.04%
-13.3%
Q4 2017$5,422,000
+191.2%
560,612
+328.2%
0.04%
+181.2%
Q3 2017$1,862,000
+102.6%
130,929
+140.7%
0.02%
+100.0%
Q2 2017$919,000
+145.7%
54,387
+56.6%
0.01%
+100.0%
Q1 2017$374,000
-33.2%
34,728
-10.5%
0.00%
-33.3%
Q4 2016$560,000
-62.3%
38,803
-36.3%
0.01%
-64.7%
Q3 2016$1,487,000
+13.9%
60,919
-7.4%
0.02%0.0%
Q2 2016$1,305,000
-35.4%
65,820
+157.7%
0.02%
+183.3%
Q1 2016$2,020,000
+287.0%
25,538
+399.9%
0.01%0.0%
Q4 2015$522,000
-79.1%
5,109
-63.6%
0.01%
-81.8%
Q3 2015$2,498,000
-7.4%
14,021
+15.5%
0.03%
-23.3%
Q2 2015$2,697,000
+311.1%
12,141
+267.8%
0.04%
+330.0%
Q1 2015$656,000
+51.9%
3,301
+9.3%
0.01%
+42.9%
Q4 2014$432,000
+11.1%
3,021
+2.0%
0.01%0.0%
Q3 2014$389,000
-41.4%
2,962
-43.8%
0.01%
-41.7%
Q2 2014$664,000
-10.3%
5,266
-6.2%
0.01%
-14.3%
Q1 2014$740,000
+30.5%
5,616
+16.2%
0.01%
+16.7%
Q4 2013$567,000
+43.9%
4,833
+30.4%
0.01%
+20.0%
Q3 2013$394,000
+17.6%
3,706
-4.6%
0.01%
+11.1%
Q2 2013$335,0003,8860.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2023
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders